None listed
Conditions
Interventions
Single group(experimental group):Blood biochemical examination
Female urine pregnancy test
MRI scan
User evaluation the device performance
Doctors evaluates the image quality
Doctors evaluate advanced
Sponsors
Peking University Third Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: inclusion criteria (all must be met): (1) 18 years or above, with the ability to act autonomously; (2) Agree to participate in this clinical trial and sign the informed consent; For using MRI contrast agent, the following inclusion items is added to the above inclusion criteria: (3) Those who clinical trial investigators believe require enhanced magnetic resonance imaging scans.
Exclusion criteria
Exclusion criteria: exclusion criteria (exclusion if any of the following criteria are met): (1) Those who have electronic implants, such as cardiac pacemakers, nerve stimulators, insulin pumps, cochlear implants, etc. (2) Those who have undergone aneurysm surgery and have an aneurysm clip in the intracranial area; (3) Those who have had heart surgery and have artificial heart values; (4) Those who have metal foreign body in the eye; (5) Those who have metal implants and prostheses, or metallic foreign bodies elsewhere in the body (excluding breast silicone implants, hip implants, knee implants and spinal implants); (6) Those who are pregnant, or have a pregnancy plan within three months, or breastfeeding women; (7) Those who are critically ill and require life support systems; (8) Those who have epilepsy or mental illness; (9) Those who have claustrophobia; (10) Those who have other conditions that the clinical trial investigators consider inappropriate to participate in the trial. For use magnetic resonance contrast agents, the following exclusion items are added to the above exclusion criteria: (11) Those who a history of allergic reactions to contrast media, bronchial asthma, or other allergic diseases; (12) Those who have used ß-adrenergic blockers; (13) Those who have severe cardiovascular diseases; (14) Those who have severe renal insufficiency, with eGFR<30ml/min.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Image quality excellent rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Convenience of device use;Stability of device functions;Convenience of workstation post-processing software;Effectiveness of advance application functions; | — |
Countries
China
Contacts
Public ContactHuishu Yuan
Peking University Third Hospital
Outcome results
None listed